Antiprogestin-progesterone interactions.
Michna
H
H
Research Laboratories of Schering AG, Berlin, FRG.
Fritzemeier
K H
KH
Parczyk
K
K
Nishino
Y
Y
Schneider
M R
MR
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006067:Gonanes / Q000627:therapeutic use; D006727:Hormone Antagonists / Q000627:therapeutic use*; D006801:Humans; D051379:Mice; D015735:Mifepristone / Q000627:therapeutic use; D011374:Progesterone / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D006067:Gonanes; D006727:Hormone Antagonists; D015735:Mifepristone; D011374:Progesterone; C053238:onapristone